Politician trade (House)

Boston Scientific (BSX): Rep. Val T. Hoyle (OR04) disclosed a sale $1K–$15K

Rep. Val T. Hoyle (OR04) disclosed a sale of Boston Scientific in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
17 days
Disclosure lag
Traded
Sep 23, 2025
Disclosed
Oct 10, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 29, 2024CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  2. Dec 11, 2024CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  3. Jul 25, 2025InsiderDirector sold ~$424K of BSX shares in the open market
  4. Jul 29, 2025InsiderDirector sold ~$310K of BSX shares in the open market
  5. Jul 31, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  6. Aug 1, 2025Insider · 2 peopleInsiders: 2 sales (~$7.0M)
  7. Aug 4, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  8. Sep 2, 2025Insider · 1 personInsiders: 2 sales (~$5.3M)
  9. Sep 11, 2025FDARecall: TENACIO Pump without InhibiZone; UPN: 72404420;
  10. Sep 12, 2025FDAFDA device clearance: LUX-Dx II Insertable Cardiac Monitor (M302); LUX-Dx II+ Insertable Cardiac Monitor (M312)
  11. Sep 23, 2025 · this disclosureCongressDisclosed sale of BSX — reported range $1,001 - $15,000

What came next

  1. Sep 24, 2025FDAFDA device clearance: LithoVue Elite Single-Use Digital Flexible Ureteroscope - Standard with pressure monitoring (M0067940000); LithoVue Elite Single-Use Digital Flexible Ureterosc…
  2. Sep 26, 2025FDAFDA device clearance: Radial Jaw 4 Pulmonary Biopsy Forceps
  3. Oct 9, 2025FDAFDA device clearance: Orca Air/Water and Suction Valves
  4. Oct 17, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  5. Oct 22, 2025Company filing · Form 8-K · ResultsReported its results
  6. Oct 22, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 22, 2025, John E. Sununu informed Boston Scientific Corporation (the “Company”) that he will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).”
  7. Oct 27, 2025InsiderDirector sold ~$1.01M of BSX shares in the open market
  8. Oct 28, 2025FDAFDA device clearance: TheraSphere 360™ Y-90 Management Platform
  9. Oct 28, 2025InsiderDirector sold ~$297K of BSX shares in the open market
  10. Oct 28, 2025CongressDisclosed partial sale of BSX — reported range $15,001 - $50,000
  11. Oct 30, 2025FDAFDA device clearance: Moses™ 200 D/F/L Laser Fiber (M0068130100); Moses™ 365 D/F/L Laser Fiber (M0068130110); Moses™ 550 D/F/L Laser Fiber (M0068130120)
  12. Oct 30, 2025FDAFDA device clearance: OBSIDIO™ Conformable Embolic (M0013972101010)
  13. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  14. Oct 31, 2025CongressDisclosed sale of BSX — reported range $1,001 - $15,000
  15. Nov 3, 2025Insider · 1 personInsiders: 3 sales (~$5.0M)
  16. Nov 6, 2025InsiderDirector sold ~$1.27M of BSX shares in the open market
  17. Nov 18, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 18, 2025, upon the recommendation of the Executive Compensation and Human Resources Committee (the “Compensation Committee”), the Board of Directors (the “Board”) of Boston Scientific Corporation (the “Company”) approved the Company’s 2026 Annual Bonus Plan effective for the performance year of January 1, 2026 through December 31, 2026 (the “2026 Annual Bonus Plan”).”
  18. Nov 18, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  19. Dec 1, 2025InsiderOfficer sold ~$1.76M of BSX shares in the open market
  20. Dec 3, 2025FDARecall: Boston Scientific Coyote OVER-THE-WIRE PTA Balloon Dilation Catheter, 4F, 1) 2.5mm x120mm, 150 cm, UPM/Model No. REF H74939186251210; 2) 3.5mm x120mm, 150 cm,…
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

Other recent filings by Rep. Val T. Hoyle (OR04)

The full history of Rep. Val T. Hoyle (OR04) is on the profile page.

How this filing works

Explore the data

Common questions

Which member of Congress traded Boston Scientific (BSX) stock, and how much?

Rep. Val T. Hoyle (OR04) disclosed a sale of Boston Scientific in the $1K–$15K range. Reported range, not an exact amount, Spouse account.

When did it happen, and when was it made public?

Traded: Sep 23, 2025. Disclosed: Oct 10, 2025. That is 17 days between the two dates.

Why is the amount a range and not an exact figure?

Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.

Where does this information come from?

From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Boston Scientific recently?

For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the BSX page.

Does this mean BSX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Boston Scientific

Everything OQRO holds on this company is on its BSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data